相关实验视频
Updated: Jan 18, 2026

08:25
Evaluating the Function of the Foot Core System in the Elderly
Published on: March 11, 2022
3.2K
在长期护理机构中,中老和老年居民中患糖尿病脚病和相关因素的风险较大
Xiaoman Yang1, Shuqi Yuan1, Qing Cai1
1School of Nursing, Fudan University, Shanghai, China.
概括
糖尿病足风险与性别,HbA1c,糖尿病持续时间,并发症和长期护理停留时间有关. 建议进行例行查和护士主导的护理以预防.
科学领域:
- 老年学是一门学科.
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 糖尿病足部并发症对老年人构成重大威胁,特别是那些居住在长期护理机构的人.
- 识别特定的风险因素对于制定针对这一弱势群体的有针对性的预防战略至关重要.
研究的目的:
- 调查长期护理机构中患有糖尿病的老年居民 (中年人和老年人) 糖尿病脚病相关的风险因素.
- 为在机构住院老年人群中为糖尿病脚护理提供有效的预防措施和临床指南的制定提供信息.
主要方法:
- 一项涉及237名75岁以上,患有2型糖尿病的居民的横截面研究在中国上海进行.
- 使用统计分析,包括t测试,单向ANOVA和多重线性回归,以确定糖尿病足的独立风险因素.
- 从五个长期护理机构收集了数据.
主要成果:
- 在研究的长期护理机构中,糖尿病足的总体风险被发现相对较低.
- 大多数参与者 (64.1%) 报告了下肢和脚部的症状.
- 确定的独立风险因素包括性别,糖化血红蛋白 (HbA1c) 水平,糖尿病持续时间,并发病病例数和住院时间 (所有p < 0.05).
结论:
- 这些发现强调了在长期护理机构实施常规糖尿病脚查方案的必要性.
- 护士主导的预防护理计划对于减轻糖尿病足风险至关重要.
- 建议采取政策举措,在这些环境中规范和加强糖尿病足预防策略.
相关概念视频
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
365
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
365
Peripheral Artery Disease IV: Nursing Management
351
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
351
Drug Dosing: Geriatric Patients
228
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
228
Diabetes: Symptoms, Diagnosis, and Complications
2.1K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
238
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
238
Pharmacodynamics in Geriatric Patients: Effects of Age
190
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
190

